Monarch Dental Announces Receipt of Nasdaq Delisting Notice and Intent to Appeal Delisting

Apr 18, 2001, 01:00 ET from Monarch Dental Corporation

    DALLAS, April 18 /PRNewswire/ -- Monarch Dental Corporation (Nasdaq: MDDS)
 today announced that The Nasdaq Stock Market, Inc. ("Nasdaq") has advised it
 that it has failed to remain eligible for continued listing on The Nasdaq
 SmallCap Market ("SmallCap Market") because its common stock has not
 maintained a $1.00 minimum bid price.  Monarch Dental also announced that it
 has requested a hearing to contest delisting as permitted by applicable Nasdaq
 procedures.  Monarch Dental expects that the delisting will be postponed until
 the hearing, which it expects will be scheduled during May 2001. In the event
 that Monarch Dental's common stock ceases to be listed either before or after
 such a hearing, Monarch Dental does not expect that its common stock will be
 listed or quoted on any securities exchange or securities quotation system,
 although market makers in Monarch Dental's stock may elect to report trades in
 Monarch Dental's common stock on the OTC Bulletin Board.
     Monarch Dental Corporation currently manages 189 dental offices serving 20
 markets in 14 states.
 
     This press release contains certain statements that are "forward-looking
 statements" as that term is defined under the Private Securities Litigation
 Reform Act of 1995 and releases issued by the Securities and Exchange
 Commission, including statements regarding the postponement of the delisting
 pending a hearing and the time period within which a hearing may be scheduled
 by Nasdaq and statements containing any inference as to the likelihood that
 Monarch Dental will be successful in its appeal of the delisting or that
 Monarch Dental will not abandon its appeal of the delisting. Such statements
 are subject to uncertainties and risks that could cause the actual results,
 performance or achievements of Monarch Dental to differ materially from
 anticipated future results, performance or achievements expressed or implied
 by such forward-looking statements. These uncertainties and risks include the
 risk that Nasdaq will delist Monarch Dental's common stock either prior to or
 after the appeal hearing despite Monarch Dental's efforts to prevent
 delisting, the risk that Monarch Dental will elect to abandon its appeal of
 the delisting for any reason, uncertainty as to the date on which the hearing
 will be scheduled by Nasdaq, uncertainties regarding the impact of the events
 disclosed in this release on Monarch Dental's operations and its stock price,
 and other risks detailed in Monarch Dental's Securities and Exchange
 Commission filings.
 
 

SOURCE Monarch Dental Corporation
    DALLAS, April 18 /PRNewswire/ -- Monarch Dental Corporation (Nasdaq: MDDS)
 today announced that The Nasdaq Stock Market, Inc. ("Nasdaq") has advised it
 that it has failed to remain eligible for continued listing on The Nasdaq
 SmallCap Market ("SmallCap Market") because its common stock has not
 maintained a $1.00 minimum bid price.  Monarch Dental also announced that it
 has requested a hearing to contest delisting as permitted by applicable Nasdaq
 procedures.  Monarch Dental expects that the delisting will be postponed until
 the hearing, which it expects will be scheduled during May 2001. In the event
 that Monarch Dental's common stock ceases to be listed either before or after
 such a hearing, Monarch Dental does not expect that its common stock will be
 listed or quoted on any securities exchange or securities quotation system,
 although market makers in Monarch Dental's stock may elect to report trades in
 Monarch Dental's common stock on the OTC Bulletin Board.
     Monarch Dental Corporation currently manages 189 dental offices serving 20
 markets in 14 states.
 
     This press release contains certain statements that are "forward-looking
 statements" as that term is defined under the Private Securities Litigation
 Reform Act of 1995 and releases issued by the Securities and Exchange
 Commission, including statements regarding the postponement of the delisting
 pending a hearing and the time period within which a hearing may be scheduled
 by Nasdaq and statements containing any inference as to the likelihood that
 Monarch Dental will be successful in its appeal of the delisting or that
 Monarch Dental will not abandon its appeal of the delisting. Such statements
 are subject to uncertainties and risks that could cause the actual results,
 performance or achievements of Monarch Dental to differ materially from
 anticipated future results, performance or achievements expressed or implied
 by such forward-looking statements. These uncertainties and risks include the
 risk that Nasdaq will delist Monarch Dental's common stock either prior to or
 after the appeal hearing despite Monarch Dental's efforts to prevent
 delisting, the risk that Monarch Dental will elect to abandon its appeal of
 the delisting for any reason, uncertainty as to the date on which the hearing
 will be scheduled by Nasdaq, uncertainties regarding the impact of the events
 disclosed in this release on Monarch Dental's operations and its stock price,
 and other risks detailed in Monarch Dental's Securities and Exchange
 Commission filings.
 
 SOURCE  Monarch Dental Corporation